{"id":"dalcetrapib-ro4607381","safety":{"commonSideEffects":[{"rate":null,"effect":"Increased uric acid levels"},{"rate":null,"effect":"Hyperuricemia"},{"rate":null,"effect":"Gout"},{"rate":null,"effect":"Headache"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"CETP is responsible for transferring cholesteryl esters from HDL to apoB-containing lipoproteins. By blocking this enzyme, dalcetrapib increases HDL-C levels and decreases LDL-C and triglycerides, potentially improving the lipid profile and reducing cardiovascular risk. This mechanism was intended to provide additional cardiovascular benefit beyond standard statin therapy.","oneSentence":"Dalcetrapib inhibits cholesteryl ester transfer protein (CETP) to increase HDL cholesterol and reduce LDL cholesterol levels.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:08:35.104Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Cardiovascular risk reduction in patients with coronary heart disease or high cardiovascular risk (Phase 3 development)"}]},"trialDetails":[{"nctId":"NCT00353522","phase":"PHASE2","title":"A Study of RO4607381 in Patients With Coronary Heart Disease (CHD) or a CHD Risk Equivalent.","status":"COMPLETED","sponsor":"Hoffmann-La Roche","startDate":"2006-07","conditions":"Coronary Heart Disease","enrollment":135},{"nctId":"NCT00658515","phase":"PHASE3","title":"A Study of RO4607381 in Stable Coronary Heart Disease Patients With Recent Acute Coronary Syndrome","status":"COMPLETED","sponsor":"Hoffmann-La Roche","startDate":"2008-04","conditions":"Coronary Heart Disease","enrollment":15871},{"nctId":"NCT00400439","phase":"PHASE2","title":"A Long Term Extension of Study NC19453 Evaluating Safety and Efficacy of RO4607381","status":"COMPLETED","sponsor":"Hoffmann-La Roche","startDate":"2007-01","conditions":"Coronary Heart Disease","enrollment":77},{"nctId":"NCT00655473","phase":"PHASE2","title":"A Study of the Effect of RO4607381 on Atherosclerotic Plaque in Patients With Coronary Heart Disease","status":"COMPLETED","sponsor":"Hoffmann-La Roche","startDate":"2008-03","conditions":"Coronary Heart Disease","enrollment":130},{"nctId":"NCT00655538","phase":"PHASE2","title":"A Study Assessing the Effect of RO4607381 on Vascular Function in Patients With Coronary Heart Disease (CHD) or CHD-Risk Equivalent Patients","status":"COMPLETED","sponsor":"Hoffmann-La Roche","startDate":"2008-02","conditions":"Coronary Heart Disease","enrollment":476},{"nctId":"NCT00697203","phase":"PHASE2","title":"A Study to Assess the Effect of RO4607381 in Patients With Relatively Low Levels of High Density Lipoprotein-Cholesterol (HDL-C)","status":"COMPLETED","sponsor":"Hoffmann-La Roche","startDate":"2005-07","conditions":"Dyslipidemia","enrollment":292},{"nctId":"NCT01363999","phase":"PHASE1","title":"A Formulation Screening Study of Dalcetrapib and Atorvastatin in Healthy Volunteers","status":"COMPLETED","sponsor":"Hoffmann-La Roche","startDate":"2011-06","conditions":"Healthy Volunteer","enrollment":24}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":11,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Dalcetrapib (RO4607381)","genericName":"Dalcetrapib (RO4607381)","companyName":"Hoffmann-La Roche","companyId":"roche","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Dalcetrapib inhibits cholesteryl ester transfer protein (CETP) to increase HDL cholesterol and reduce LDL cholesterol levels. Used for Cardiovascular risk reduction in patients with coronary heart disease or high cardiovascular risk (Phase 3 development).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}